Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001551152-25-000020
Filing Date
2025-02-14
Accepted
2025-02-14 13:17:23
Documents
164
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K abbv-20241231.htm   iXBRL 10-K 3783439
2 EX-4.1 abbv-20241231xex41.htm EX-4.1 140976
3 EX-19 abbv-20241231xex19.htm EX-19 18175
4 EX-21 abbv-20241231xex21.htm EX-21 21184
5 EX-23 abbv-20241231xex23.htm EX-23 8038
6 EX-31.1 abbv-20241231xex311.htm EX-31.1 9356
7 EX-31.2 abbv-20241231xex312.htm EX-31.2 9397
8 EX-32.1 abbv-20241231xex321.htm EX-32.1 4834
9 EX-32.2 abbv-20241231xex322.htm EX-32.2 4755
15 abbv-20241231_g1.jpg GRAPHIC 15145
16 abbv-20241231_g2.gif GRAPHIC 748
17 abbv-20241231_g3.jpg GRAPHIC 119525
18 abbv-20241231xex19001.jpg GRAPHIC 166511
19 abbv-20241231xex19002.jpg GRAPHIC 216722
20 abbv-20241231xex19003.jpg GRAPHIC 193452
21 abbv-20241231xex19004.jpg GRAPHIC 190420
22 abbv-20241231xex19005.jpg GRAPHIC 213823
23 abbv-20241231xex19006.jpg GRAPHIC 151937
24 abbv-20241231xex21001.jpg GRAPHIC 82042
25 abbv-20241231xex21002.jpg GRAPHIC 75642
26 abbv-20241231xex21003.jpg GRAPHIC 73922
27 abbv-20241231xex21004.jpg GRAPHIC 72775
28 abbv-20241231xex21005.jpg GRAPHIC 77363
29 abbv-20241231xex21006.jpg GRAPHIC 67661
30 abbv-20241231xex21007.jpg GRAPHIC 67263
31 abbv-20241231xex21008.jpg GRAPHIC 73291
32 abbv-20241231xex21009.jpg GRAPHIC 71505
33 abbv-20241231xex21010.jpg GRAPHIC 68714
34 abbv-20241231xex21011.jpg GRAPHIC 75171
35 abbv-20241231xex21012.jpg GRAPHIC 65385
36 abbv-20241231xex21013.jpg GRAPHIC 68900
37 abbv-20241231xex21014.jpg GRAPHIC 78675
38 abbv-20241231xex21015.jpg GRAPHIC 80864
39 abbv-20241231xex21016.jpg GRAPHIC 77195
40 abbv-20241231xex21017.jpg GRAPHIC 70885
41 abbv-20241231xex21018.jpg GRAPHIC 79519
42 abbv-20241231xex21019.jpg GRAPHIC 80614
43 abbv-20241231xex21020.jpg GRAPHIC 79706
44 abbv-20241231xex21021.jpg GRAPHIC 76254
45 abbv-20241231xex21022.jpg GRAPHIC 73242
46 abbv-20241231xex21023.jpg GRAPHIC 74308
47 abbv-20241231xex21024.jpg GRAPHIC 78948
48 abbv-20241231xex21025.jpg GRAPHIC 74723
49 abbv-20241231xex21026.jpg GRAPHIC 73760
50 abbv-20241231xex21027.jpg GRAPHIC 75295
51 abbv-20241231xex21028.jpg GRAPHIC 75042
52 abbv-20241231xex21029.jpg GRAPHIC 85165
  Complete submission text file 0001551152-25-000020.txt   24935027

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abbv-20241231.xsd EX-101.SCH 113331
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abbv-20241231_cal.xml EX-101.CAL 176150
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abbv-20241231_def.xml EX-101.DEF 662742
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abbv-20241231_lab.xml EX-101.LAB 1434005
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abbv-20241231_pre.xml EX-101.PRE 1041203
167 EXTRACTED XBRL INSTANCE DOCUMENT abbv-20241231_htm.xml XML 3856175
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35565 | Film No.: 25626115
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)